Correlation between laminin-5 immunohistochemistry and human papillomavirus status in squamous cervical carcinoma

Journal of Clinical Pathology

Volumn 60, Issue 8, 2007, Pages 896-901

  Boulet, G A V ^a   Schrauwen, I ^a   Sahebali, S ^a   Horvath, C ^a   Depuydt, C E ^b   Vereecken, A ^b   Vanden Broeck, D ^a   Van Marck, E A ^c   Bogers, J J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Laboratory for Clinical Pathology (Labo Lokeren Campus RIATOL)   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

KALININ; PROTEIN E6; PROTEIN E7;

ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; GENES, VIRAL; HELA CELLS; HUMAN PAPILLOMAVIRUS 6; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 34547824745     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.037549     Document Type: Article

References (25)

1. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer J 2003;9:348-59.
2. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
3. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
4. Boyle DC, Smith JR. Infection and cervical intraepithelial neoplasia. Int J Gynecol Cancer 1999;9:177-86.
5. Tjiong MY, Out TA, Ter Schegget J, et al. Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract: a review. Int J Gynecol Cancer 2001;11:9-17.
6. Nebesio CL, Mirowski GW, Chuang TY. Human papillomavirus: clinical significance and malignant potential. Int J Dermatol 2001;40:373-9.
7. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91.
8. Fehrmann F, Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003;22:5201-7.
9. Moberg M, Gustavsson I, Wilander E, et al. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 2005;92:891-4.
10. Josefsson A, Livak K, Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J Clin Microbiol 1999;37:490-6.
11. Dalstein V, Riethmuller D, Pretet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003;106:396-403.
12. Moberg M, Gustavsson I, Gyllensten U. Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer 2004;112:854-9.
13. Park JS, Hwang ES, Park SN, et al. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 1997;65:121-9.
14. Corden SA, Sant-Cassia LJ, Easton AJ, et al. The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol 1999;52:275-82.
15. Skyldberg B, Salo S, Eriksson E, et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999;91:1882-7.
16. Kohlberger P, Beneder Ch, Horvat R, et al. Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol 2003;89:391-4.
17. Stoltzfus P, Salo S, Eriksson E, et al. Laminin-5 gamma2 chain expression facilitates detection of invasive squamous cell carcinoma of the uterine cervix. Int J Gynecol Pathol 2004;23:215-22.
18. Depuydt CE, Vereecken AJ, Salembier GM, et al. Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer 2003;88:560-6.
19. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41:3221-8.
20. Manos MM, Ting Y, Wright DK, et al. Cancer cells 7: molecular diagnostics of human cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
21. Kalantari M, Karlsen F, Kristensen G, et al. Disruption of the E1 and E2 reading frames of HPV16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 1998;17:146-53.
22. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
23. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 1995;92:1654-8.
24. Swan DC, Tucker RA, Tortolero-Luno G, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999;37:1030-1.
25. Kulmala S-MA, Syrjänen SM, Gyllensten UB, et al. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2006;56:513-517.